A recent article on Forbes.com discusses the significance of Aptar Pharma’s expanded relationship with Propeller Health to deliver Connected Medicines across multiple therapeutic areas. Announced May 30, this partnership, which includes a strategic equity investment by Aptar Pharma in Propeller Health, is “a move that signals the pharmaceutical industry’s growing interest in digital therapeutics.”
Read the full article to find out more.
